DFDA

Intestinal Resection and Anastomosis for Atresia/Stenosis

Treatment for Digestive Congenital Anomalies

Effectiveness
90%
Safety Score
45%
Clinical Trials
200
Participants
5K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
45
DangerousModerateSafe
Treatment Details
Time to Effect
Immediate surgical relief, feeding tolerance over 2-6 weeks
Treatment Duration
Acute (surgical), 1-4 weeks hospitalization, long-term nutritional support/follow-up
Evidence Quality
MODERATE
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$500
Monitoring:$120,000
Side Effect Mgmt:$15,000
Total Annual:$135,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
70
Outcome-Based Costs
Cost per Responder
$142,632
Cost per Remission
$159,412
Intestinal Resection and Anastomosis for Atresia/Stenosis Outcomes

for Digestive Congenital Anomalies

Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+95%
Remission Rate
+85%
Common Side Effects
Anastomotic leak
+7%
Short Bowel Syndrome (if extensive resection)
+10%
Intestinal obstruction due to adhesions
+8%
Infection
+7%

Sources:

oup.com
nih.gov
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov